RightFit Trial Directory

Parkinson's Disease clinical trials in Rochester, MN

5 recruiting parkinson's disease studies with a site in Rochester, MN.

All trials in Rochester, MN · All Parkinson's Disease trials

RecruitingPhase 3NCT06170788

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Sponsor: Merck Sharp & Dohme LLC

Minneapolis, MN · Rochester, MN · +13 more sites

RecruitingPhase 3NCT06989112

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Sponsor: AstraZeneca

Marshall, MN · Minneapolis, MN · Rochester, MN · +60 more sites

RecruitingPhase not listedNCT07868614

Intraoperative Microelectrode Recordings Using MAVEN Compared to Standard Recording Apparatuses

Sponsor: Mayo Clinic

Rochester, MN

RecruitingPhase not listedNCT07567794

GBPDC: Gut-Brain in PD Consortium Master Protocol

Sponsor: Duke University

Rochester, MN · +6 more sites

RecruitingPhase not listedNCT01799915

Natural History Study of Synucleinopathies

Sponsor: NYU Langone Health

Rochester, MN · +4 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.